Roberta Minari

3.7k total citations · 1 hit paper
66 papers, 2.5k citations indexed

About

Roberta Minari is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Roberta Minari has authored 66 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 43 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Roberta Minari's work include Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Research Studies (17 papers) and Cancer Genomics and Diagnostics (14 papers). Roberta Minari is often cited by papers focused on Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Research Studies (17 papers) and Cancer Genomics and Diagnostics (14 papers). Roberta Minari collaborates with scholars based in Italy, France and United States. Roberta Minari's co-authors include Alessandro Leonetti, Marcello Tiseo, Elisa Giovannetti, Paola Perego, Marcello Tiseo, Sugandhi Sharma, Paola Bordi, Francesco Facchinetti, Letizia Gnetti and Silvia La Monica and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Roberta Minari

60 papers receiving 2.5k citations

Hit Papers

Resistance mechanisms to osimertinib in EGFR-mutated non-... 2019 2026 2021 2023 2019 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    2019 893 citations Alessandro Leonetti, Roberta Minari et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Minari Italy 25 1.7k 1.5k 1.1k 585 208 66 2.5k
Shang‐Gin Wu Taiwan 29 1.9k 1.1× 1.5k 1.0× 955 0.8× 683 1.2× 160 0.8× 64 2.6k
Anthony M. D’Amelio United States 16 1.6k 0.9× 1.4k 1.0× 1.4k 1.2× 697 1.2× 459 2.2× 37 2.9k
Eiki Ichihara Japan 29 1.5k 0.9× 1.6k 1.1× 945 0.8× 395 0.7× 195 0.9× 153 2.4k
Alessandro Leonetti Italy 18 1.2k 0.7× 1.1k 0.8× 848 0.7× 424 0.7× 157 0.8× 54 2.0k
Teresa Morán Spain 26 1.9k 1.1× 1.6k 1.1× 1.0k 0.9× 627 1.1× 177 0.9× 130 2.7k
Kenji Tomizawa Japan 26 1.5k 0.9× 1.3k 0.9× 874 0.8× 393 0.7× 142 0.7× 72 2.4k
Riyaz Shah United Kingdom 19 3.3k 1.9× 2.8k 1.9× 1.1k 1.0× 708 1.2× 183 0.9× 48 3.9k
Luc Friboulet France 22 1.6k 0.9× 1.5k 1.1× 1.3k 1.1× 625 1.1× 272 1.3× 57 2.6k
Kathryn H. Brown United Kingdom 15 1.8k 1.0× 1.4k 1.0× 931 0.8× 460 0.8× 155 0.7× 30 2.4k
Anh T. Le United States 20 2.3k 1.4× 2.1k 1.4× 1.4k 1.2× 869 1.5× 491 2.4× 56 3.5k

Countries citing papers authored by Roberta Minari

Since Specialization
Citations

This map shows the geographic impact of Roberta Minari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Minari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Minari more than expected).

Fields of papers citing papers by Roberta Minari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Minari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Minari. The network helps show where Roberta Minari may publish in the future.

Co-authorship network of co-authors of Roberta Minari

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Minari. A scholar is included among the top collaborators of Roberta Minari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Minari. Roberta Minari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monica, P. Della, et al.. (2025). Circulating tumor DNA monitoring in advanced mutated melanoma (LIQUID-MEL). PubMed. 8. 100295–100295. 1 indexed citations
2.
Mazzaschi, Giulia, M.A. Manini, Roberta Minari, et al.. (2025). EP.11.05 Prognostic Value of Hb/RDW and Its Correlation With Immune-Inflammatory Profile in NSCLC Receiving First-Line Immunotherapy. Journal of Thoracic Oncology. 20(10). S784–S784.
3.
Leonetti, Alessandro, Roberta Minari, Francesco Bonatti, et al.. (2024). Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC. Clinical Lung Cancer. 25(8). e436–e445.e9. 2 indexed citations
4.
Perrone, Fabiana, Francesco Facchinetti, Benedetta Pellegrino, et al.. (2024). Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making. Tumori Journal. 110(6). NP11–NP15.
5.
Mazzaschi, Giulia, Fabiana Perrone, Giuseppe Maglietta, et al.. (2024). Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors. Journal of Immunotherapy. 47(9). 388–394. 2 indexed citations
6.
Alfieri, Roberta, Claudia Fumarola, Mara Bonelli, et al.. (2024). Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines. Biochemical Pharmacology. 228. 116161–116161. 4 indexed citations
7.
Volta, Francesco, Silvia La Monica, Alessandro Leonetti, et al.. (2023). Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators. Targeted Oncology. 18(6). 953–964. 8 indexed citations
8.
Ventura, Luigi, Letizia Gnetti, Gianluca Milanese, et al.. (2023). Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible Insights. Archivos de Bronconeumología. 59(7). 418–426.
9.
Leonetti, Alessandro, Francesco Bonatti, Fabiana Perrone, et al.. (2022). Role of ctDNA for the detection of minimal residual disease in resected non-small cell lung cancer: a systematic review. Translational Lung Cancer Research. 11(12). 2588–2600. 13 indexed citations
10.
Minari, Roberta, Francesco Bonatti, Giulia Mazzaschi, et al.. (2021). PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors. Tumori Journal. 108(1). 47–55. 9 indexed citations
11.
Ferlenghi, Francesca, Laura Scalvini, Federica Vacondio, et al.. (2021). A sulfonyl fluoride derivative inhibits EGFRL858R/T790M/C797S by covalent modification of the catalytic lysine. European Journal of Medicinal Chemistry. 225. 113786–113786. 40 indexed citations
12.
Mazzaschi, Giulia, Gianluca Milanese, Denise Madeddu, et al.. (2021). Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients. Tumori Journal. 108(1). 86–92. 6 indexed citations
13.
Mazzaschi, Giulia, Alessandro Leonetti, Roberta Minari, et al.. (2021). Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy. Current Treatment Options in Oncology. 22(11). 96–96. 10 indexed citations
14.
Mazzaschi, Giulia, Gianluca Milanese, Paolo Pagano, et al.. (2020). Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 31. 105781–105781. 5 indexed citations
15.
Mazzaschi, Giulia, Roberta Minari, Alessandra Zecca, et al.. (2020). Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients. Lung Cancer. 148. 1–11. 82 indexed citations
16.
Mazzaschi, Giulia, Gianluca Milanese, Paolo Pagano, et al.. (2020). Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC. Lung Cancer. 144. 30–39. 27 indexed citations
17.
Monica, Silvia La, Roberta Minari, Daniele Cretella, et al.. (2019). Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion. Targeted Oncology. 14(5). 619–626. 38 indexed citations
18.
Minari, Roberta, Paola Bordi, Silvia La Monica, et al.. (2018). Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC. Journal of Thoracic Oncology. 13(6). e89–e91. 33 indexed citations
19.
Leonetti, Alessandro, Francesco Facchinetti, Giulio Rossi, et al.. (2018). BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall. Cancer Treatment Reviews. 66. 82–94. 121 indexed citations
20.
Bersanelli, Melissa, Roberta Minari, Paola Bordi, et al.. (2016). L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR -Mutated NSCLC. Journal of Thoracic Oncology. 11(10). e121–e123. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shang‐Gin Wu Breakdown of academic impact, for papers by Anthony M. D’Amelio Breakdown of academic impact, for papers by Eiki Ichihara Breakdown of academic impact, for papers by Alessandro Leonetti Breakdown of academic impact, for papers by Teresa Morán Breakdown of academic impact, for papers by Kenji Tomizawa Breakdown of academic impact, for papers by Riyaz Shah Breakdown of academic impact, for papers by Luc Friboulet Breakdown of academic impact, for papers by Kathryn H. Brown Breakdown of academic impact, for papers by Anh T. Le
Rankless by CCL
2026